Neuroendocrine differentiation and prognosis in breast adenocarcinoma

Histopathology

Volumn 40, Issue 3, 2002, Pages 215-222

  Miremadi, A ^a   Pinder, S E ^a   Lee, A H S ^a   Bell, J A ^a   Paish, E C ^a   Wencyk, P ^a   Elston, C W ^a   Nicholson, R I ^a   Blamey, R W ^a   Robertson, J F ^a   Ellis, I O ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Breast; Carcinoma; Neuroendocrine; Prognosis

Indexed keywords

CHROMOGRANIN A; ESTROGEN RECEPTOR; NEURON SPECIFIC ENOLASE; SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; BREAST ADENOCARCINOMA; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; NEUROENDOCRINOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, NEUROENDOCRINE; CHROMOGRANIN A; CHROMOGRANINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; SURVIVAL ANALYSIS; SYNAPTOPHYSIN;

EID: 18344386395     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01336.x     Document Type: Article

References (44)

1. Introduction
2. Chromogranin-reactive endocrine cells in argyrophilic carcinomas ('carcinoids') and normal tissue of the breast
3. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells
4. Argyrophilic cells in mammary carcinoma
5. Expression of the neuroendocrine phenotype in carcinomas of the breast
6. Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas
7. A study of different markers for neuroendocrine differentiation in breast carcinomas
8. Neuron specific enolase-positive breast carcinomas
9. Synaptophysin in human breast carcinomas
10. Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?
11. Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression after radical prostatectomy
12. The occurrence and clinicopathological significance of serotonin immunoreactive cells in large bowel carcinoma
13. Endocrine cells and prognosis in patients with colorectal carcinoma
14. Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features
15. The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas
16. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
17. Pathological prognostic factors in breast cancer. II. Histo-logical type. Relationship with survival in a large study with long-term follow-up
18. Pathological prognostic factors in breast cancer. III. Vascular invasion: Relationship with recurrence and survival in a large study with long-term follow-up
19. Evaluation of the prognostic value of triple node biopsy in early breast cancer
20. Uber die carcinoide wuchsform des carcinoma mammae, insbesondere des carcinoma solidum (gelatinosum) mammae
21. Primary carcinoid tumor of the breast. A report of eight patients
22. Carcinomas of the breast with endocrine differentiation: A review
23. Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters
24. Neuroendocrine differentiation in carcinomas of the breast: A study of 51 cases
25. Endocrine markers in argyrophilic carcinomas of the breast
26. Argyrophilic breast carcinomas: Evidence of lactational differentiation
27. The significance of argyrophilia in human breast carcinomas
28. A silver nitrate stain for alpha-2 cells in human pancreatic islets
29. The nature of breast dense core granules: Uranaffin reactivity
30. An ultrastructural evaluation of the cell organelle specificity of the uranaffin reaction in two human endocrine neoplasms
31. Immunocytochemistry in diagnostic pathology
32. Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour
33. Ki67 labelling index: An independent predictor of progression in prostate cancer treated by radical prostatectomy
34. The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long-term follow-up study with patients treated by radical prostatectomy
35. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma
36. Neuroendocrine differentiation and prognosis in prostatic adenocarcinoma
37. Neuroendocrine differentiation in prostate cancer: Enhanced prediction of progression after radical prostatectomy
38. The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy
39. Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment
40. Mixed endocrine-exocrine tumors of the gastrointestinal tract
41. Divergent differentiation in neuroendocrine lung tumors
42. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer
43. Neuroendocrine tumors of the lung
44. Chromogranin gene expressions in colorectal adenocarcinomas